OMDA
Omada Health, Inc. Health Care Services-Health Services Russell 3000
$18.73Close
$1.1BMarket cap
$10.94 – $25.6752-week range
Nov 5, 2026Next report · after the close
Highlights
Cautions
- Not in an uptrend 4 of 8 trend conditions
- Lagging the market RS 45 · weaker than 55% of stocks over 12 months
- Far from its high 27% below its 52-week high
- Results soon Nov 5, 2026, in 4 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
27%
1wk
down 1.2%
price change
1mo
down 10.0%
price change
12-month return
down 23%
market up 11% ·
its own down 37%
F-score
—
— Not assessed
Altman Z″
2.28
Moderate risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
4.8×
price / book
Earnings yield
down 1.4%
EBIT / enterprise value
Cheaper than
30%
of the market · expensive
Revenue growth
up 53%
year on year
EPS growth
—
latest quarter
Sales growth
up 43%
latest quarter · +1 pts
ROE
down 6%
return on equity
Free cash margin
up 7%
$16.9M FCF
D/E
0.00
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Piotroski tests
Repair signals
- FCF turned positive ($-35M → $17M)
- Long-term debt down 100% ($0.0B → $0.0B)
- Gross margin 60.6% → 65.7%
Trade setup
ATR%
5.3%
$0.99 a day · 2×ATR $16.74
RS
45 / 99
vs the universe
Trend
4 / 8
trend template
Relative volume
0.8×
vs 50-day average
Up/down volume
1.09
50 sessions
Implied move
—
no option chain · report Nov 5, 2026
Trend template · 4 of 8
- Price above the 150 and 200-day averages: fails
- 150-day average above the 200-day: passes
- 200-day average rising for a month: passes
- 50-day average above the 150 and 200-day: passes
- Price above the 50-day average: fails
- At least 30% above the 52-week low: passes
- Within 25% of the 52-week high: fails
- RS rank 70 or higher: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Shareholders diluted The share count rose 616.3% over the year, from 8m to 58m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Aug 6, 2026
Last shock
Oct 13, 2026-16% in one session2.0× volumeno filing matched+2% since
Financials
- Gross 66%
- Net -5%
- Free cash 7%
- Cash
- Long-term debt
| FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|
| Revenue | $122.8M | $169.8M | $260.2M |
| Gross margin | 57% | 61% | 66% |
| Operating income | -$66.0M | -$43.7M | -$12.0M |
| Net income | -$67.5M | -$47.1M | -$12.8M |
| Net margin | -55% | -28% | -5% |
| Earnings per share | -$9.52 | -$6.11 | -$0.35 |
| Free cash flow | -$50.2M | -$34.8M | $16.9M |
| Free cash margin | -41% | -20% | 7% |
| Cash | $115.6M | $76.4M | $222.0M |
| Long-term debt | — | $29.8M | $0 |
| Shareholders' equity | -$350.1M | -$384.4M | $229.7M |
| Shares outstanding | — | 8.16m | 58.43m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 7, 2026 | Quarterly ↗ | Jun 30, 2026 | 38d |
| May 8, 2026 | Quarterly ↗ | Mar 31, 2026 | 38d |
| Mar 6, 2026 | Annual ↗ | Dec 31, 2025 | 65d |
| Nov 7, 2025 | Quarterly ↗ | Sep 30, 2025 | 38d |
| Aug 8, 2025 | Quarterly ↗ | Jun 30, 2025 | 39d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 6, 2026 | Results · Director or officer change ↗ |
| Jun 16, 2026 | Shareholder vote ↗ |
| May 7, 2026 | Results ↗ |
| Mar 5, 2026 | Results ↗ |
| Jan 12, 2026 | Results ↗ |
| Nov 6, 2025 | Results ↗ |
| Aug 7, 2025 | Results ↗ |
| Jun 9, 2025 | Charter or bylaws · Other events ↗ |